News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,732 Results
Type
Article (8024)
Company Profile (140)
Press Release (476567)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166827)
Career Advice (304)
Deals (25755)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9761)
Job Trends (8572)
News (238286)
Policy (17903)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33172)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (262)
Approvals (10371)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3632)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47852)
Collaboration (1240)
Commercialization (3)
Compensation (1452)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (739)
Cystic fibrosis (85)
Data (5630)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4179)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73750)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87643)
Executive appointments (699)
FDA (12374)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (911)
Gene editing (125)
Generative AI (10)
Gene therapy (315)
GLP-1 (289)
Government (951)
Grass and pollen (2)
Guidances (281)
Healthcare (9336)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (42)
IPO (12404)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8658)
Medtech (8798)
Mergers & acquisitions (14381)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1819)
NextGen: Class of 2026 (3154)
Non-profit (846)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (503)
Peanut (31)
People (41245)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15460)
Phase 2 (21369)
Phase 3 (14393)
Pipeline (7263)
Policy (18)
Postmarket research (1572)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3021)
Recruiting (6)
Regulatory (14813)
Reports (21)
Research institute (582)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (52)
Last 7 days (423)
Last 30 days (1629)
Last 365 days (19078)
2026 (12127)
2025 (19252)
2024 (22999)
2023 (26554)
2022 (34622)
2021 (37204)
2020 (33509)
2019 (23278)
2018 (17478)
2017 (18771)
2016 (17924)
2015 (24287)
2014 (21686)
2013 (18151)
2012 (20225)
2011 (20445)
2010 (20337)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17881)
Australia (2097)
California (11914)
Canada (3129)
China (518)
Colorado (482)
Connecticut (408)
Delaware (208)
Europe (24649)
Florida (1783)
Georgia (376)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1199)
Massachusetts (7833)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2615)
New Mexico (12)
New York (2814)
North Carolina (1269)
North Dakota (4)
Northern California (5965)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2246)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (76)
South Dakota (1)
Southern California (4947)
Tennessee (119)
Texas (1931)
United States (38723)
Utah (358)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (923)
West Virginia (1)
Wisconsin (73)
484,732 Results for "accuray inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China’s National Medical Products Administration
Accuray Incorporated announced that the registration dossier for the Accuray Precision® Treatment Planning System has been approved by the Chinese National Medical Products Administration.
June 12, 2024
·
4 min read
BioMidwest
Accuray to Participate in the Jefferies Global Healthcare Conference 2024
Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024.
May 22, 2024
·
1 min read
Business
Accuray Reports Fiscal 2024 Third Quarter Financial Results
Accuray Incorporated reported financial results for the third quarter and nine-months ended March 31, 2024.
May 1, 2024
·
17 min read
BioMidwest
Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
Accuray Incorporated announced that as part of its commitment to advancing patient care the company has opened a new training center in Genolier, Switzerland, that will serve as the European education hub for radiosurgery and radiotherapy product training, and sharing of best practices and innovative techniques using the latest model Accuray CyberKnife® and Radixact® Radiation Treatment Delivery Systems and Accuray Precision® Treatment Planning System.
April 18, 2024
·
3 min read
Business
Accuray Reports Fiscal 2024 Second Quarter Financial Results
Accuray Incorporated reported financial results for the second quarter and six-months ended December 31, 2023.
January 31, 2024
·
17 min read
BioMidwest
Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Accuray Incorporated announced its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March 12-13, 2024.
February 27, 2024
·
1 min read
BioMidwest
Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
Accuray Incorporated announced an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department’s capabilities.
June 20, 2024
·
5 min read
BioMidwest
Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience.
April 25, 2024
·
7 min read
Business
Accuray Reports Fiscal 2024 First Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2024 ended September 30, 2023.
November 7, 2023
·
14 min read
Business
Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2024, ended March 31, 2024, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 1, 2024.
April 17, 2024
·
1 min read
1 of 48,474
Next
